KoBioLabs, Inc (KOSDAQ:348150)
South Korea · Delayed Price · Currency is KRW 6,140.00
+210.00 (3.54%)
At close: Sep 15, 2025
KoBioLabs Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Net Income | -8,281 | -5,298 | -13,853 | -21,921 | -15,382 | -55,072 | Upgrade |
Depreciation & Amortization | 2,759 | 2,578 | 1,515 | 908.06 | 232.72 | 209.89 | Upgrade |
Loss (Gain) From Sale of Assets | 0.4 | 123.43 | - | 6.85 | - | - | Upgrade |
Loss (Gain) From Sale of Investments | -146.57 | - | - | -11.51 | -7.33 | - | Upgrade |
Stock-Based Compensation | 256.73 | 265.42 | 800.35 | 1,695 | 1,571 | 2,405 | Upgrade |
Other Operating Activities | 941.83 | 942.99 | -2,408 | 3,127 | -704.12 | 43,163 | Upgrade |
Change in Accounts Receivable | 2,911 | -950.57 | -1,266 | -702.54 | 2,478 | -2,570 | Upgrade |
Change in Inventory | -2,092 | -3,202 | -487.87 | -725.03 | -150.65 | 73.85 | Upgrade |
Change in Accounts Payable | 6.03 | 2.62 | - | - | - | -68.59 | Upgrade |
Change in Unearned Revenue | - | -5.45 | -114.78 | -512.29 | 361.64 | 206.07 | Upgrade |
Change in Other Net Operating Assets | -2,992 | 1,188 | 1,982 | 1,580 | -880.97 | -1,118 | Upgrade |
Operating Cash Flow | -6,636 | -4,355 | -13,832 | -16,556 | -12,481 | -12,771 | Upgrade |
Capital Expenditures | -198.61 | -1,640 | -15,133 | -14,683 | -5,512 | -124.98 | Upgrade |
Sale of Property, Plant & Equipment | 0.99 | 1.21 | 0.81 | - | - | - | Upgrade |
Sale (Purchase) of Intangibles | -115.5 | -6.5 | -428.32 | -81.81 | -39.07 | -150.81 | Upgrade |
Investment in Securities | 8,928 | 6,113 | 23,960 | -46,421 | -25,454 | 21,294 | Upgrade |
Other Investing Activities | -146.59 | 1,967 | -217.46 | -748.86 | -19.09 | -26.33 | Upgrade |
Investing Cash Flow | 8,468 | 6,434 | 8,192 | -61,814 | -31,154 | 20,992 | Upgrade |
Short-Term Debt Issued | - | 4,800 | - | - | - | - | Upgrade |
Long-Term Debt Issued | - | 3,200 | 4,000 | 6,059 | 13,346 | - | Upgrade |
Total Debt Issued | 5,800 | 8,000 | 4,000 | 6,059 | 13,346 | - | Upgrade |
Short-Term Debt Repaid | - | -1,075 | - | - | - | - | Upgrade |
Long-Term Debt Repaid | - | -13,582 | -339.15 | -95.54 | -39.3 | -15.92 | Upgrade |
Total Debt Repaid | -9,526 | -14,657 | -339.15 | -95.54 | -39.3 | -15.92 | Upgrade |
Net Debt Issued (Repaid) | -3,726 | -6,657 | 3,661 | 5,964 | 13,307 | -15.92 | Upgrade |
Issuance of Common Stock | 113.53 | 151.32 | 395.17 | 10,750 | 4,350 | 31,061 | Upgrade |
Other Financing Activities | -7.48 | -7.48 | -9.89 | 19,596 | -0 | 0 | Upgrade |
Financing Cash Flow | -3,615 | -6,513 | 4,046 | 36,310 | 55,741 | 31,045 | Upgrade |
Foreign Exchange Rate Adjustments | -37.13 | 76.26 | 1,208 | -199.67 | -40.36 | 82.39 | Upgrade |
Net Cash Flow | -1,821 | -4,358 | -386.23 | -42,260 | 12,066 | 39,348 | Upgrade |
Free Cash Flow | -6,835 | -5,995 | -28,966 | -31,239 | -17,993 | -12,896 | Upgrade |
Free Cash Flow Margin | -9.84% | -8.77% | -87.41% | -269.17% | -621.88% | -280.86% | Upgrade |
Free Cash Flow Per Share | -352.59 | -312.55 | -1563.45 | -1859.88 | -1121.36 | -1202.99 | Upgrade |
Cash Interest Paid | 701.5 | 670.65 | 303.02 | 140.63 | 8.88 | 14.53 | Upgrade |
Cash Income Tax Paid | - | 15.9 | 249.35 | 239.81 | 180.4 | 56.09 | Upgrade |
Levered Free Cash Flow | -5,927 | -11,457 | -20,874 | -24,552 | -16,000 | -90,604 | Upgrade |
Unlevered Free Cash Flow | -5,553 | -10,733 | -19,916 | -23,501 | -15,904 | -90,162 | Upgrade |
Change in Working Capital | -2,167 | -2,967 | 113.36 | -359.91 | 1,808 | -3,477 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.